Showing results (121-130 of 338) with videos related to
Sort By:
Pageof 34
Revue Medicale De Liege|April 8, 2017
[Increased heart rate as a risk factor and treatment target in patients with heart failure]J Tridetti, F Krzesinski, V D'orio, et al.Journal of Bacteriology|January 1, 1980
Polarity of amber mutations in ribosomal protein genes of Escherichia coliT Cabezón, G Delcuve, M Faelen, et al.Antimicrobial Agents and Chemotherapy|January 1, 1993
Candidicidal activity of the human recombinant myeloperoxidase systemC Tournay, P Majerus, M Pourtois, et al.Chemosphere|July 9, 2005
Mitigation of azinphos-methyl in a vegetated stream: comparison of runoff- and spray-driftJ M Dabrowski, E R Bennett, A Bollen, et al.Hybridoma|June 1, 1987
Monoclonal antibodies against human growth hormone releasing factor, hGRF(1-44)NH2M Francotte, M J Gama-Caldas, J Urbain, et al.FEBS Letters|August 11, 1986
High-level production and isolation of human recombinant alpha 1-proteinase inhibitor in yeastM Hoylaerts, A Weyens, A Bollen, et al.Bioscience Reports|April 1, 1986
The alpha 2 cDNA sequence of human haptoglobin carries a bacterial promoter functional in vivoA van der Straten, R Loriau, A Herzog, et al.FEBS Letters|March 12, 1984
Characterization of human haptoglobin cDNAs coding for alpha 2FS beta and alpha 1S beta variantsA van der Straten, A Herzog, T Cabezón, et al.Structural Equation Modeling : a Multidisciplinary Journal|July 31, 2019
BIC and Alternative Bayesian Information Criteria in the Selection of Structural Equation ModelsKenneth A Bollen, Jeffrey J Harden, Surajit Ray, et al.The Biochemical Journal|July 15, 1978
Resistance to the aminoglycoside antibiotic neamine in Escherichia coli. A new mutant whose NeaR phenotype results from the cumulative effects of two distinct mutationsG Delcuve, T Cabezón, A Herzog, et al.Pageof 34